Introduction

Pet food and animal feed represent a specialised category within food manufacturing that requires tailored approaches to ensure safety, efficacy, and compliance. Animal feed encompasses all products manufactured for consumption by non-food-producing animals, including domestic pets such as cats, dogs, and exotic species. This definition extends beyond complete diets to include premixes, nutritional supplements, and medicated feedstuffs. Pet food manufacturing operates within the broader regulatory framework of feed legislation, which establishes comprehensive standards from raw material sourcing through to final product release. The sector is distinct from general food manufacturing in that manufacturers must account for multiple animal species, their specific nutritional requirements, and the potential for harm arising from species-inappropriate formulations or contaminated ingredients intended for animals with sensitivities.

Significance and Intent

The requirements governing pet food and animal feed production serve several critical functions within a food manufacturer’s operations. First, they ensure that products are formulated, designed and manufactured specifically for their intended animal recipients, preventing inadvertent harm that might arise from unsuitable compositions or processing conditions. Second, these requirements protect against cross-species contamination—a significant concern when a single manufacturing facility produces feed for multiple species with varying tolerance levels to specific ingredients or medicinal substances. Third, they establish robust controls for medicated feedstuffs, where the presence of veterinary medicines requires precise management, accurate concentration verification, and rigorous prevention of unintended carryover to non-medicated products.

From a broader perspective, compliance with these requirements demonstrates that manufacturers take animal health seriously and operate with the same rigour expected of human food production. This builds consumer confidence in pet food products and protects manufacturing businesses from reputational damage or regulatory intervention resulting from contaminated or incorrectly formulated feeds. The intent is fundamentally preventive: to anticipate hazards associated with animal-specific production activities and systematically eliminate or control them before products reach the market.

Overview of Compliance

Compliance with pet food and animal feed requirements necessitates a documented management system that integrates with—and complements—the broader food safety plan and quality management system. The system should encompass documented procedures addressing product formulation and specification, species-specific handling protocols, segregation of production areas and equipment for different animal types, controls for medicated materials, supplier approval processes for specialist ingredients and premixes, staff training focused on animal feed specificities, and record-keeping that demonstrates traceability and safety verification.

These documented systems should be aligned with operational practices through regular review and update cycles, staff involvement in procedure development, and verification that documented requirements reflect actual working methods. Where discrepancies emerge between documented procedures and field practices, manufacturers should investigate the reason—whether the documentation requires clarification, the operational practice requires adjustment, or both require refinement. This iterative alignment ensures that documentation remains a working tool rather than a compliance exercise disconnected from reality.

Documented Systems

Product Formulation and Species-Specific Procedures

Food manufacturers producing pet food and animal feed should establish and maintain a comprehensive documented procedure detailing how products are formulated and designed for their intended animal recipients. This procedure must confirm that each product is appropriate for the specific species or animal type for which it is intended. For example, a feed formulated for cats may contain ingredients or nutrient profiles unsuitable for dogs, while feed for exotic species may have entirely different requirements.

The procedure should reference the product specification (as required under general product control requirements), which should explicitly state the intended species, intended use, and any age-group or health-status considerations. This specification becomes a critical control point: production staff must verify that the correct formulation is being manufactured before production commences, and quality assurance personnel should verify formulation accuracy against specification before product release.

Where a manufacturer’s product range includes pet food or animal feed for different animal species, documented procedures should detail how the site manages the segregation of ingredients, raw materials, products, and rework that could be harmful if fed to unintended recipients. These procedures should address the physical separation of storage areas, the use of dedicated equipment, the sequencing of production activities, and the cleaning protocols required between production runs for different species. Documentation should specify which areas of the facility are designated for specific animal species and establish clear, visible signage to remind staff of these designations.

Management of Medicated Raw Materials and Finished Products

Where a site manufactures, processes or packs pet food or animal feed products containing medicinal substances, specific documented procedures must govern the identification, handling, and control of medicated materials throughout the production process. These procedures should detail the following elements:

Identification and receipt of medicated materials. Documented procedures should establish how medicated raw materials, processing aids, intermediate products, and finished products are identified upon receipt and throughout storage. This identification might involve labelling, physical segregation (such as storage in clearly marked containers), colour-coded systems, or electronic tracking systems. The procedure should ensure that no medicated material can be accidentally introduced into non-medicated products, and that no medicated product can be inadvertently released as non-medicated product. Records should demonstrate that materials have been verified as medicated and contain the correct medicinal substance at the expected concentration before use in production.

Supplier approval for medicated materials. The documented procedure should reference the requirement that all suppliers of medicated raw materials, premixes, and medicinal substances meet supplier approval requirements equivalent to those specified in general raw material control requirements. Documentation should evidence that the supplier has been audited or certified, that specifications have been agreed, and that the supplier operates effective traceability and quality assurance systems. For medicated materials, this is particularly critical because any deviation in active substance concentration or the presence of unintended medicinal substances could render the finished product unsafe or non-compliant with veterinary prescriptions or legislative requirements.

Specific procedures for medicated materials handling. Given the significance of medicinal substances in animal feed, manufacturers should document specific work instructions for the handling of medicated materials. These instructions should address the following: the mechanism for ensuring that medicated materials are stored separately from non-medicated materials; the procedures for verifying the identity and concentration of medicinal substances before use; the calculations or formulae used to ensure correct inclusion rates in finished products; the equipment or processes used to achieve homogeneous distribution of medicinal substances throughout the batch; and the specific personnel authorised to handle or oversee handling of medicated materials. Where medicinal substances are added manually, the procedure should describe verification steps to confirm that the correct quantity has been added and homogeneously mixed. Where automated systems are used, the procedure should detail validation evidence demonstrating that the system correctly dispenses the specified quantity.

Prevention of cross-contamination between medicated and non-medicated products. A critical requirement is the establishment of documented procedures to prevent contamination of non-medicated products with medicinal substances from medicated products. These procedures might involve: the use of dedicated equipment for medicated product lines that is never used for non-medicated products; the sequencing of production so that medicated products are manufactured only after non-medicated products (meaning any residual contamination would not affect a product intended to be non-medicated); comprehensive cleaning procedures performed between medicated and non-medicated production runs, with documented verification that cleaning has been effective; and the maintenance of time segregation, whereby production areas are used exclusively for medicated or non-medicated products during defined periods, with effective cleaning between uses.

Documentation should specify the cleaning chemicals and concentrations to be used, the frequency and method of cleaning, visual inspection points to verify cleaning effectiveness, and microbiological or chemical testing (where applicable) to confirm that residual levels of medicinal substances meet acceptable limits. For production sequences involving different medicated products, procedures should reference applicable medication sequencing guidelines that identify which sequences are acceptable (for example, a non-medicated feed may be produced after a medicated feed only if the medicinal substance carryover presents no risk to the species for which the subsequent feed is intended).

Labelling of medicated products. Documented procedures should ensure that all medicated pet food and animal feed products bear appropriate labelling that clearly identifies the presence of medicinal substances, provides dosage information where applicable, specifies the target species and age group, identifies any withdrawal periods (where relevant), and includes any required warnings or contraindications. The procedure should describe how labelling is verified before product dispatch to ensure that medicated products are never released with non-medicated labelling, and vice versa.

Waste disposal of medicated materials. The procedure should address the safe and legally compliant disposal of medicated raw materials and finished products. This might involve returning unused medicated premixes or medicinal premixes to suppliers, destruction through incineration or other approved methods, or disposal through licensed waste contractors. Documentation should demonstrate that disposal methods comply with relevant legislation and that records of disposal are maintained for the required retention period.

Documentation of Ingredient and Raw Material Sourcing

A documented procedure should detail how ingredients and raw materials used in pet food and animal feed production are sourced, assessed for suitability, and verified for safety. This procedure should reference general supplier approval and raw material acceptance requirements, but with additional considerations specific to animal feed.

For ingredients sourced for non-food-producing animal feed that might derive from by-products or secondary materials, the procedure should confirm that all suppliers are approved and that specifications clearly define the quality, safety, and compositional requirements of the material. This is particularly important where animal-derived materials are used, as legislation in many jurisdictions places restrictions on the use of certain animal proteins in animal feed (for example, prohibitions on intraspecies recycling or the use of certain rendered materials in feed for specific species). Documented procedures should detail how the manufacturer verifies supplier compliance with these legislative restrictions and how records are maintained to demonstrate traceability of animal protein sources.

Where a manufacturer uses ingredients that may contain allergens or that could pose risks to animals with sensitivities, the documented procedure should address allergen declaration, testing protocols, and segregation of allergen-containing materials to prevent unintended cross-contamination. For example, a facility producing limited-antigen diets for animals with food allergies should maintain detailed documentation of supplier approvals, ingredient testing for species-specific proteins, cleaning procedures, and equipment segregation to minimise the risk of adventitious presence of non-declared proteins.

Practical Application

Formulation Verification and Production Planning

In practical terms, the application of pet food and animal feed requirements begins during the planning phase of production. Before production of a medicated or species-specific feed commences, responsible production and quality assurance personnel should verify that the correct formulation is specified for that production run. This verification should involve checking the production order or work instruction against the corresponding product specification to confirm that the species, intended use, formulation, and any special requirements (such as medicinal substance inclusion or allergen status) align precisely.

For medicated feeds, this verification step should include a check that the veterinary prescription (where applicable) has been received and that the production order reflects the prescriptive requirements—including the target animal species, age group, the medicinal substance and its concentration, the quantity to be produced, and any special handling or labelling instructions. Production should not commence until this verification is complete and documented.

Production staff working with pet food and animal feed should be trained to understand the significance of species-specific formulations and the potential consequences of cross-species contamination. Staff should know which areas of the facility are designated for specific animal species and should be alert to any deviation from expected practice. For example, if staff are accustomed to producing only dog feed in a particular production line and suddenly receive instructions to produce cat feed, this change should trigger awareness and verification that the formulation and all raw materials are appropriate for feline use.

Equipment Segregation and Production Sequencing

Where equipment is used for production of feeds for different animal species or for both medicated and non-medicated products, practical application requires clear procedures for equipment cleaning and transition between production runs. Cleaning procedures should be documented in sufficient detail that any competent production worker can understand exactly what must be done, what cleaning chemicals and concentrations are required, how long cleaning should take, and what verification steps must be completed before production resumes.

In many facilities, practical segregation is achieved through dedicated equipment: equipment used only for a specific species’ feed, or equipment used only for medicated products. Where this is feasible, it is often the most effective approach and the simplest to verify. Where dedicated equipment is not feasible, time segregation combined with validated cleaning procedures becomes essential. Documented schedules should specify which products are manufactured in which areas at which times, and should ensure that cleaning windows are provided between different product types. Records of actual cleaning activities—including start and completion times, identification of the person performing cleaning, and any observations regarding cleaning effectiveness—should be maintained to demonstrate that the schedule was followed in practice.

For medicated products, production sequencing should follow established medication sequencing guidelines. For example, if a facility produces both a medicated feed containing a specific antimicrobial substance and a non-medicated feed for the same animal species, the non-medicated feed should be produced first, followed by the medicated feed. Any subsequent non-medicated feed produced on the same equipment should only proceed if medication sequencing guidelines confirm that residual carryover of the antimicrobial to the non-medicated feed presents acceptable risk to that animal species.

Raw Material Receipt and Verification

When medicated raw materials, premixes, or medicinal substances arrive at the facility, receiving personnel should verify that the delivery matches the purchase order, that the material is correctly identified (including clear indication that it is medicated), and that the medicated material is stored in a designated, clearly marked area separate from non-medicated materials. Receiving records should document the date and time of receipt, the supplier, the material identity, the lot or batch number, the quantity received, and the person who received and verified the material.

For non-medicated raw materials used in pet food production, particularly where allergen management is critical, receiving personnel should verify that the material matches the specification, that any required certificates of analysis have been provided, and that the material is suitable for its intended use. Where ingredients are sourced for limited-antigen or hypoallergenic pet food products, species-specific testing (such as PCR testing for undeclared animal proteins) might be necessary at receipt or shortly thereafter to confirm that the ingredient does not contain contaminant proteins that would compromise the product’s integrity.

Staff Training and Communication

Staff engaged in pet food and animal feed production require specific training that addresses the particular risks associated with these products. Training should cover the following topics: the significance of animal species distinction (why a product for cats differs fundamentally from a product for dogs, and why using the wrong formulation could harm animals); the identification and handling of medicated materials; the risks of cross-species or medicated-to-non-medicated contamination; the specific cleaning procedures and production sequences required; and the procedures for identifying and reporting any deviations or concerns regarding product safety.

Training records should document that staff have received training, that the training covered relevant topics, and that staff understanding has been verified (for example, through a practical demonstration or a simple knowledge check). Retraining should be provided when procedures change, when a staff member transfers to a different role, or when monitoring reveals that understanding has diminished.

Communication between production, quality assurance, and management is particularly important where medicated feeds are produced. Clear communication channels should ensure that any uncertainty regarding formulation, medicinal substance concentration, or production sequencing is resolved before production commences. Where a concern arises—such as a question about whether a cleaning procedure was effective enough, or whether the correct medicinal substance concentration was achieved—staff should feel confident reporting this concern to a supervisor or quality assurance personnel, and the concern should be investigated and resolved.

Record-Keeping and Traceability

Practical application of requirements includes maintenance of records that demonstrate compliance and enable traceability. For medicated feeds, these records should include: the veterinary prescription (where applicable) specifying the medicinal substance, concentration, target species, and quantity; the production batch record documenting the formulation used, the raw materials and medicinal substances added, the quantities, the personnel involved, any deviations or unusual events, and the verification steps completed; the testing records confirming the concentration of medicinal substances in the finished product (which should be undertaken using validated methods and should verify homogeneity across the batch); records of medication sequencing decisions confirming that the sequence of products produced on shared equipment meets established guidelines; cleaning records documenting cleaning activities, times, and verification that cleaning was effective; and labelling records confirming that medicated products were labelled correctly and that no medicated product was released with non-medicated labelling.

For non-medicated pet food, particularly where species-specific requirements are significant, records should include: the production work instruction or order specifying the species, formulation, and any special requirements; documentation of raw material receipt and verification; production batch records documenting formulation compliance, production parameters, and verification steps; and where allergen management is critical, records of allergen testing or species-specific protein verification conducted at raw material receipt and, where appropriate, in finished product.

All records should be retained for a period that exceeds the shelf life of the product plus a minimum retention period (typically 12 months), and should be readily retrievable in the event of a complaint, recall, or regulatory investigation.

Pitfalls to Avoid

Inadequate Species Segregation

A frequent failing observed in facilities producing pet food or animal feed is insufficient physical or procedural segregation between different animal species. Manufacturers might, for example, produce dog feed and cat feed on the same production line with only cleaning between runs, but fail to implement sufficiently rigorous cleaning procedures or monitoring to prevent cross-contamination. This is particularly problematic where the species differ markedly in their tolerances to specific ingredients.

Food manufacturers can overcome this by mapping their production process to identify all points where cross-species contamination could occur and establishing specific controls for each point. Where feasible, dedicated equipment for specific species is the most robust control. Where this is not practical, validated cleaning procedures combined with documented production sequencing and monitoring for effectiveness provide additional assurance. Manufacturers should also consider the practical reality of staff carrying knowledge of which equipment is designated for which species; clear, visible labelling and regular training help prevent human error.

Inadequate Control of Medicated Materials

A significant pitfall involves insufficient segregation, identification, or traceability of medicated materials. For example, a facility might store medicated premix and non-medicated premix in adjacent containers without clear differentiation, leading to the accidental addition of medicated material to a non-medicated batch. Alternatively, staff might fail to verify that a medicinal substance has been added to a batch, resulting in finished product released with incorrect (lower) medicinal concentration.

Manufacturers should address this through rigorous identification systems (such as colour-coded containers or electronic tracking), clear work instructions that mandate verification at each stage, and supervised production of medicated batches where a responsible person oversees formulation additions and confirms homogeneous mixing. Documentation of the verification step—with the signature or electronic confirmation of the person who verified—provides evidence that the critical step was not overlooked.

Inadequate Cleaning Verification

Many manufacturers implement cleaning procedures but fail to verify effectively that cleaning has been completed to the required standard. For example, a procedure might specify visual inspection to confirm absence of visible residues, but staff might perform only a cursory visual check rather than a rigorous inspection. In facilities producing medicated feeds, inadequate cleaning verification can result in unacceptable residual medicinal substance carryover to subsequent non-medicated batches.

Manufacturers should address this through the use of multiple verification methods. Visual inspection provides a first line of assurance, but should be supplemented by other methods such as ATP bioluminescence testing (which detects residual organic material and microorganisms), microbiological testing where microbial contamination is a concern, or chemical testing to confirm absence of residual medicinal substances. The specific verification method should be selected based on the nature of the residue that must be removed. Records of verification results should be maintained and reviewed for trends; if verification results show a persistent pattern of cleaning inadequacy (for example, ATP readings consistently elevated despite cleaning), this triggers investigation and corrective action.

Inadequate Documentation of Production Decisions

Where medication sequencing or species-specific segregation decisions are made, these decisions are often not documented. This means that if a product is later recalled or a complaint is received, the facility cannot demonstrate that the production sequence was deliberate and based on established guidelines, or that species-appropriate formulations were used.

Manufacturers should address this by documenting production sequencing decisions in the batch record or in a separate record linked to the batch record. The documentation should identify which products were produced, in what sequence, and why that sequence was acceptable (for example, by reference to medication sequencing guidelines or to species compatibility). This documentation provides evidence of compliance and supports effective recall management if needed.

Insufficient Staff Knowledge

Staff working in pet food and animal feed production sometimes lack understanding of why their tasks matter or why deviation from procedures could be harmful. For example, a production worker might see no difference between dog feed and cat feed formulations if they lack training in the different nutritional requirements and safety concerns for each species. This lack of knowledge makes staff vulnerable to shortcuts or deviations that seem trivial but could compromise product safety.

Manufacturers should address this through comprehensive, ongoing training that explains not just the “what” and “how” of procedures, but also the “why”—the consequences of non-compliance and the significance of the product for animal health. Training should be practical and relevant to staff roles, with opportunities for questions and clarification. Verification that staff understand key concepts (for example, through a simple demonstration or a knowledge-check conversation) helps identify gaps in understanding and allows retraining to be targeted effectively.

In Summary

Pet food and animal feed production represents a distinct challenge within food manufacturing, requiring specific attention to species-appropriate formulation, segregation of different animal types, and rigorous control of medicated materials. Effective compliance rests on the foundation of documented procedures that are clear, practical, and actually implemented in the facility.

The most important elements to remember are these: first, every pet food or animal feed product must be formulated and manufactured specifically for its intended animal species, and this intent must be verified before production and documented throughout the process. Second, where multiple species are produced, physical or procedural segregation must prevent the accidental mixing of species-inappropriate materials. Third, where medicated feedstuffs are produced, medicinal substances must be identified, handled, and verified with exceptional rigour, and cross-contamination to non-medicated products must be prevented through validated cleaning, production sequencing, or dedicated equipment.

Fourth, all staff involved in pet food and animal feed production must understand the significance of the requirements and the potential consequences of non-compliance, supported by ongoing training and clear communication. Fifth, comprehensive record-keeping enables manufacturers to demonstrate compliance, support traceability investigations, and respond effectively to complaints or recalls. Finally, manufacturers should recognise that pet food and animal feed requirements are not an isolated addition to general food safety management, but rather an integrated extension of the broader food safety plan and quality management system.

By implementing these principles with genuine commitment to animal welfare and product safety, food manufacturers can build confidence among customers and regulatory authorities, protect their reputation and brand, and most importantly, ensure that the pet foods and animal feeds they produce genuinely serve the health and wellbeing of the animals for which they are intended.